# A Study to Evaluate the Mass Balance Absorption and AME of VBR

> **NCT04637139** · PHASE1 · COMPLETED · sponsor: **Assembly Biosciences** · enrollment: 6 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Vebicorvir (VBR)

## Key facts

- **NCT ID:** NCT04637139
- **Lead sponsor:** Assembly Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2020-12-22
- **Final completion:** 2020-12-22
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04637139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04637139, "A Study to Evaluate the Mass Balance Absorption and AME of VBR". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04637139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*